The antineutrophil cytoplasmic antibodies (ANCA typical or not) in current medical practice

被引:4
|
作者
Renaudineau, Y. [3 ]
Beauvillard, D. [3 ]
Segalen, I. [2 ,3 ]
Leroyer, C. [1 ]
Le Meur, Y. [2 ]
Youinou, P. [1 ]
机构
[1] CHU Brest, Hop Cavale Blanche, Serv Pneumol, F-29609 Brest, France
[2] CHU Brest, Hop Cavale Blanche, Serv Nephrol, F-29609 Brest, France
[3] CHU Brest, Hop Morvan, Immunol Lab, F-29609 Brest, France
来源
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2011年 / 26卷 / 01期
关键词
Antineutrophil cytoplasmic antibodies (ANCA); Vasculitis; Proteinase; 3; Myeloperoxidase (MPO); INTERNATIONAL CONSENSUS STATEMENT; WEGENERS-GRANULOMATOSIS; NECROTIZING GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; SYSTEMIC VASCULITIS; DISEASE-ACTIVITY; AUTOANTIBODIES; PROTEINASE-3; NEUTROPHILS; MYELOPEROXIDASE;
D O I
10.1016/j.immbio.2010.12.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Antineutrophil cytoplasmic antibodies (ANCA) are important serological markers mostly for the small vessel systemic vasculitides. Numerous reports have established an interest for the combination of the indirect immunofluorescence (IFI) and the ELISA anti-PR3 and anti-MPO in such indication. However, conflicting results may exist between IFI and ELISA that require additional assays and such special measures are important to help and avoid clinical misinterpretation. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [21] Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse
    Yamaguchi, Makoto
    Ando, Masahiko
    Kato, Sawako
    Katsuno, Takayuki
    Kato, Noritoshi
    Kosugi, Tomoki
    Sato, Waichi
    Tsuboi, Naotake
    Yasuda, Yoshinari
    Mizuno, Masashi
    Ito, Yasuhiko
    Matsuo, Seiichi
    Maruyama, Shoichi
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (10) : 1853 - 1860
  • [22] Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease
    Savige, Judy
    Trevisin, Michelle
    Pollock, Wendy
    JOURNAL OF IMMUNOLOGICAL METHODS, 2018, 458 : 1 - 7
  • [23] DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) USING THE IMMUNOPEROXIDASE METHOD
    INAMURA, K
    FUKASE, S
    OHTA, N
    SAKATA, K
    KOIKE, Y
    ACTA OTO-LARYNGOLOGICA, 1994, : 218 - 220
  • [24] DIAGNOSTIC SPECIFICITY OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN OTORHINOLARYNGOLOGICAL DISEASES
    FUKASE, S
    OHTA, N
    INAMURA, K
    KIMURA, Y
    AOYAGI, M
    KOIKE, Y
    ACTA OTO-LARYNGOLOGICA, 1994, : 204 - 207
  • [25] The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil
    Gao, Ying
    Chen, Min
    Ye, Hua
    Guo, Xiao-Hui
    Zhao, Ming-hui
    Wang, Hai-yan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (01) : 55 - 60
  • [26] ANTINEUTROPHIL CYTOPLASM ANTIBODIES (ANCA)
    SAVIGE, JA
    DAVIES, DJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1990, 20 (03): : 271 - 274
  • [27] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN INFLAMMATORY RHEUMATIC DISEASES - IMMUNODIAGNOSTIC AND IMMUNOPATHOGENETIC ASPECTS
    CSERNOK, E
    GROSS, WL
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1995, 54 (01): : 26 - 38
  • [28] A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies
    Savige, JA
    Paspaliaris, B
    Silvestrini, R
    Davies, D
    Nikoloutsopoulos, T
    Sturgess, A
    Neil, J
    Pollock, W
    Dunster, K
    Hendle, M
    JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (08) : 568 - 575
  • [29] Antineutrophil cytoplasmic antibodies
    Sebastiani, G. D.
    REUMATISMO, 2009, 61 (01) : 69 - 76
  • [30] Antineutrophil cytoplasmic antibodies
    De Bandt, M
    REVUE DU RHUMATISME, 1998, 65 (06): : 415 - 428